Zhen-Xin Zeng - Fujian Med Univ, Shengli Clin Med Coll, Fuzhou, Fujian, Peoples R China

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: a propensity score matching analysis

Yi-Nan Li, Shao-Ming Wei, Yang-Kai Fu,Zhen-Xin Zeng, Li-Ming Huang,Jia-Hui Lv, Wei-Zhao Chen,Yong-Gang Wei, Zhi-Bo Zhang,Jian-Yin Zhou, Jia-Yi Wu,Mao-Lin Yan

FRONTIERS IN ONCOLOGY (2024): 1372123-1372123

引用0浏览0WOS引用

Prognostic value of pathological response for patients with unresectable hepatocellular carcinoma undergoing conversion surgery

Zhen-Xin Zeng,Jia-Yi Wu,Jun-Yi Wu,Zhi-Bo Zhang,Kai Wang, Shao-Wu Zhuang,Bin Li,Jian-Yin Zhou, Zhong-Tai Lin,Shu-Qun Li,Yi-Nan Li, Yang-Kai Fu,

Liver Cancer (2024)

引用0浏览0引用

Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study

Xiangye Ou,Junyi Wu,Jiayi Wu, Yangkai Fu,Zhenxin Zeng,Shuqun Li,Yinan Li, Deyi Liu,Han Li,Bin Li,Jianyin Zhou, Shaowu Zhuang,

Cancer research and treatment (2024)

引用0浏览0WOS引用

Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study

Shuqun Li,Junyi Wu,Jiayi Wu,Yangkai Fu,Zhenxin Zeng,Yinan Li,Han Li,Weijia Liao,Maolin Yan

Front Immunol（2023）

引用0浏览0WOS引用

Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: a multicenter study

Li-Ming Huang,Zhen-Xin Zeng,Jun-Yi Wu,Yi-Nan Li, Jin-Xiu Wang, Yang-Kai Fu,Jia-Yi Wu, Shao-Ming Wei,Jia-Hui Lv,Wei-Zhao Chen,Rong-Fa Huang,Shu-Qun Cheng,

FRONTIERS IN ONCOLOGY（2023）

引用0浏览0WOS引用

Outcomes of Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma Converted by Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibodies: A Multicenter Retrospective Study

Jia-Yi Wu,Zhi-Bo Zhang,Jian-Yin Zhou,Jing-Peng Ke,Yan-Nan Bai,Yu-Feng Chen,Jun-Yi Wu,Song-Qiang Zhou,Shuang-Jia Wang,Zhen-Xin Zeng,Yi-Nan Li,Fu-Nan Qiu,

LIVER CANCERno. 3 (2023): 229-237

引用3浏览0WOS引用

The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors

Zhen-Xin Zeng,Jia-Yi Wu,Jun-Yi Wu,Yi-Nan Li, Yang-Kai Fu,Zhi-Bo Zhang, De-Yi Liu,Han Li, Xiang-Ye Ou, Shao-Wu Zhuang,Mao-Lin Yan

Hepatology internationalno. 2 (2023): 651-660

引用0浏览0WOS引用

Shuqun Li,Junyi Wu,Jiayi Wu,Yangkai Fu,Zhenxin Zeng,Yinan Li,Han Li,Weijia Liao,Maolin Yan

FRONTIERS IN IMMUNOLOGY (2023)

引用0浏览0引用

Should associating liver partition and portal vein ligation for staged hepatectomy be applied to hepatitis B virus-related hepatocellular carcinoma patients with cirrhosis? A multi-center study

Jia-Hui Lv,Wei-Zhao Chen,Yi-Nan Li, Jin-Xiu Wang, Yang-Kai Fu,Zhen-Xin Zeng,Jia-Yi Wu,Shuang-Jia Wang,Xiao-Xiao Huang,Li-Ming Huang,Rong-Fa Huang,Yong-Gang Wei,

HPB（2022）

引用2浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn